Met Life Investment Management, LLC Assertio Holdings, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 09, 2024
BUY
$2.52 - $5.69 $118,253 - $267,008
46,926 New
46,926 $120,000
Q3 2023

Apr 29, 2024
BUY
$2.52 - $5.69 $44,508 - $100,496
17,662 Added 60.35%
46,926 $120,000
Q3 2023

Nov 14, 2023
BUY
$2.52 - $5.69 $44,508 - $100,496
17,662 Added 60.35%
46,926 $120,000
Q2 2023

Apr 29, 2024
BUY
$5.0 - $7.66 $146,320 - $224,162
29,264 New
29,264 $158,000
Q2 2023

Aug 10, 2023
BUY
$5.0 - $7.66 $146,320 - $224,162
29,264 New
29,264 $158,000

Others Institutions Holding ASRT

# of Institutions
114
Shares Held
37.2M
Call Options Held
755K
Put Options Held
39.5K
View Full List

About Assertio Holdings, Inc.

ASRT Quotes by TradingView
  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $58.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email